Stem Cell Discovery

Volume 5, Issue 3 (July 2015)

ISSN Print: 2161-6760   ISSN Online: 2161-6787

Google-based Impact Factor: 1.33  Citations  

Isolation and Characterization of Multipotent and Pluripotent Stem Cells from Human Peripheral Blood

HTML  XML Download Download as PDF (Size: 1453KB)  PP. 19-32  
DOI: 10.4236/scd.2015.53003    6,163 Downloads   9,172 Views  Citations

ABSTRACT

Stem cells are commonly classified based on the developmental stage from which they are isolated, although this has been a source of debate amongst stem cell scientists. A common approach classifies stem cells into three different groupings: Embryonic Stem Cells (ESCs), Umbilical Cord Stem Cells (UCBSCs) and Adult Stem Cells (ASCs), which include stem cells from bone marrow (BM), fat tissue (FT), engineered induced pluripotent (IP) and peripheral blood (PB). By definition stem cells are progenitor cells capable of self-renewal and differentiation hypothetically “ab infinitum” into more specialized cells and tissue. The main intent of this study was to determine and characterize the different sub-groups of stem cells present within the human PB-SCs that may represent a valid opportunity in the field of clinical regenerative medicine. Stem cells in the isolated mononucleated cells were characterized using a multidisciplinary approach that was based on morphology, the expression of stem cell markers by flowcytometry and fluorescence analysis, RT-PCR and the capacity to self-renew or proliferate and differentiate into specialized cells. This approach was used to identify the expression of hematopoietic, mesenchymal, embryonic and neural stem cell markers. Both isolated adherent and suspension mononucleated cells were able to maintain their stem cell properties during in-vitro culture by holding their capacity for proliferation and differentiation into osteoblast cells, respectively, when exposed to the appropriate induction medium.

Share and Cite:

Gargiulo, C. , Pham, V. , Thuy Hai, N. , Nguyen, K. , Phuc, P. , Abe, K. , Flores, V. and Shiffman, M. (2015) Isolation and Characterization of Multipotent and Pluripotent Stem Cells from Human Peripheral Blood. Stem Cell Discovery, 5, 19-32. doi: 10.4236/scd.2015.53003.

Cited by

[1] Innovative Concepts and Recent Breakthrough for Engineered Graft and Constructs for Bone Regeneration: A Literature Systematic Review
Materials, 2022
[2] COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines
Children, 2022
[3] New Translational Trends in Personalized Medicine: Autologous Peripheral Blood Stem Cells and Plasma for COVID-19 Patient
Journal of Personalized …, 2022
[4] COVID-19 Infection in children, infants and pregnant subjects: an overview of recent insights and therapies
Microorganisms, 2021
[5] The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants
2021
[6] Mesenchymal Stem Cells: The Secret Children's Weapons against the SARS-CoV-2 Lethal Infection
2021
[7] Stem cells and regenerative medicine
2020
[8] Innovative Scaffold Solution for Bone Regeneration Made of Beta-Tricalcium Phosphate Granules, Autologous Fibrin Fold, and Peripheral Blood Stem Cells
2019
[9] Novel Therapeutic Strategy in the Treatment of Diabetes Type 2, the Use of Autologous Peripheral Blood Stem Cells in 15 Patients: Is There Any Relation with …
2018
[10] Novel Therapeutic Strategy in the Treatment of Diabetes Type 2, the Use of Autologous Peripheral Blood Stem Cells in 15 Patients: Is There Any Relation with the …
2017
[11] Novel Therapeutic Strategy in the Treatment of Diabetes Type 2, the Use of Autologous Peripheral Blood Stem Cells in 15 Patients: Is There Any Relation with the Incretin-GLP-1/GIP Axis?
British Journal of Medicine & Medical Research, 2017
[12] Characteristics of peripheral blood stem cells: 2D-Gel electrophoresis and kinetic parameter of exocytosis
Current Biomarkers (Formerly: Recent Patents on Biomarkers), 2016
[13] Human Peripheral Blood Stem Cells can be a Solution to Diabetes Mellitus Type 2 a Preliminary Study on 14 Patients
2016
[14] A Unique Case of Crossover Second Toe Syndrome treated by Autologous Peripheral Blood Stem Cells
2016
[15] Toxoplasmosis Gondii Infection and Diabetes Mellitus Type 2 Treated by Using Autologous Peripheral Blood Stem Cells a Unique Case Report of a Caucasian 83 Year Old Lady
Biomedical Research and Therapy, 2015
[16] Autologous Peripheral Blood Stem Cells and γ/δ T Cells May Improve Immunity in Treating Secondary Bacteremic Infection in HIV Infected Patient
Stem Cell Discovery, 2015
[17] Toxoplasmosis Gondii Infection and Diabetes Mellitus Type 2 Treated by Using Autologous Peripheral Blood Stem Cells a Unique Case Report of a Caucasian …
2015
[18] Toxoplasmosis Gondii Infection and Diabetes Mellitus Type 2 Treated by Using Autologous Peripheral Blood Stem Cells a Unique Case Report of a …
2015

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.